Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.25.0.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development (including $2,335,000 and $4,584,000 from a related party) 5,798,000 6,466,000
Selling, general and administrative (including $230,000 and $2,220,000 of stock compensation granted to officers, directors, and employees and for services during the years ended December 31, 2024 and 2023, respectively) 8,566,000 7,110,000
Loss from Operations (14,364,000) (13,576,000)
Other Income (Expense)    
Interest income 402,000 780,000
Interest expense (213,000)
Change in fair value of warrant liability 800,000 4,797,000
Gain on extinguishment of share settled debt 547,000
Unrealized gain on short-term investments 48,000
Other 20,000
Total Other Income, Net 1,202,000 5,979,000
Net Loss $ (13,162,000) $ (7,597,000)
Net Loss Per Share - Basic $ (6.94) $ (5.64)
Net Loss Per Share - Diluted $ (6.94) $ (5.64)
Weighted average common shares outstanding - basic 1,897,375 1,347,713
Weighted average common shares outstanding - diluted 1,897,375 1,347,713